Abstract
Cinemark Holdings, Inc. will report first-quarter 2026 results on May 1, 2026, Pre-Market; this preview highlights consensus expectations for revenue and earnings alongside key operational drivers and analyst views into the print.
Market Forecast
Consensus for the first quarter of 2026 points to revenue of 628.89 million US dollars, up 16.99% year over year, and adjusted EPS of -0.16, improving 0.57% year over year from a low base. The forecast also embeds EBIT of 13.89 million US dollars, reflecting a sharp year-over-year rebound from prior-year comparables.
Management’s core operating engine remains theatrical attendance and associated monetization, with early-quarter box-office momentum supported by a record domestic Easter weekend that should carry through April’s release slate. Within the revenue mix, admissions remain the largest stream at 1.54 billion US dollars on a trailing basis, while concessions at 1.23 billion US dollars offer the greatest leverage to per-patron spend and mix; overall revenue is forecast to rise 16.99% year over year in the quarter.
Last Quarter Review
For the fourth quarter of 2025, Cinemark reported revenue of 776.30 million US dollars (down 4.67% year over year), a gross profit margin of 48.16%, GAAP net income attributable to the company of 34.10 million US dollars for a 4.39% net margin, and adjusted EPS of 0.16 (down 51.52% year over year).
Quarter on quarter, net income contracted by 31.11%, reflecting a lighter release cadence and tougher comparison periods while gross margin held near 48%. In the revenue mix, admissions represented 49.59% and concessions 39.40% of trailing revenue, with total quarterly revenue at 776.30 million US dollars down 4.67% year over year as mix and timing of wide-release films shaped attendance and monetization.
Current Quarter Outlook
Admissions and attendance trajectory in Q1 2026
The starting point for this quarter’s model is attendance, which drives admissions and unlocks in-theater consumption. Consensus expects 628.89 million US dollars in revenue, implying a notable sequential step-down from the holiday-heavy fourth quarter but a 16.99% year-over-year increase, consistent with easier prior-year comps and a healthier film slate cadence. An early signal arrived in April with a record domestic five-day Easter weekend for the circuit, indicating broad-based demand elasticity when confronted with mass-appeal titles and family-oriented programming.
Attendance quality is nearly as important as absolute footfall. Premium showings (such as large-format screens and upgraded auditoriums) tend to lift ticket pricing and improve the admissions revenue yield per patron. The company’s format mix and pricing strategies allow it to capture upside when tentpoles cluster, and the record Easter period suggests favorable momentum into the latter weeks of the quarter, even if titles are uneven week-to-week. Against this backdrop, the small improvement implied in EPS (from the prior-year first quarter) aligns with operational leverage off a low base, but the absolute level of EPS remains negative in seasonally softer months, leaving the magnitude of attendance the critical swing factor.
The bridge from admissions to EBIT in the quarter will hinge on film rental terms and the concentration of must-see titles. When studios command higher settlement terms for blockbuster content, admissions gross margin can compress; yet a balanced slate with broader genre representation tends to moderate average film costs. The model-implied EBIT of 13.89 million US dollars, a steep rebound year over year from a depressed comparison, suggests improved throughput and cost absorption even as the company navigates variable distribution expenses tied to the slate.
Concessions monetization and per-patron spend
Concession sales are the second revenue pillar and often the highest incremental margin opportunity. Trailing figures put concessions at 1.23 billion US dollars (39.40% of the revenue mix), which reflects the scale of that profit engine when attendance is healthy. In quarters when family and group attendance leads, per-capita spend historically trends favorably, helped by menu breadth, bundling, and upsizing; the early Easter outperformance should be supportive for concession mix into April, with beverages, hot foods, and shareables typically key drivers of basket size.
The margin contribution from concessions is especially sensitive to volume because labor and operating inputs have an important fixed component at the auditorium level. As attendance rises, units per transaction and prep/serve efficiency often improve, leading to beneficial operating leverage. Given consensus implies only a modest improvement in EPS versus the prior-year first quarter, the base case suggests higher concession volumes partly offset higher wage and input costs. The degree of margin improvement will also be shaped by promotional intensity and loyalty-related discounts, which can raise frequency while slightly moderating yield per ticket; net-net, this remains a favorable tradeoff when throughput accelerates.
One structural support for concession resiliency is the steady expansion of loyalty and subscription features that encourage repeat visits and predictable patron economics. When members visit more often, they tend to maintain or expand concession purchasing habits, which supports both volume and merchandising tests. With a record Easter period signaling strong family engagement, the chances improve that concession per-capita spend remains constructive through the quarter, even if week-to-week film variability leads to attendance bumps and lulls.
Key stock price swing factors this quarter
The first swing factor is attendance versus slate timing. The consensus revenue figure embeds a year-over-year increase of 16.99%, and the record Easter weekend provides a supportive near-term read, but a handful of titles can disproportionately affect outcomes late in April. Any shortfall or upside surprise in footfall could rapidly flow through admissions and then concessions, pushing EPS above or below the -0.16 consensus.
The second swing factor is operating leverage against fixed theater-level costs. Cinemark’s cost structure includes labor, lease, utilities, and maintenance that cannot fully flex down in softer weeks, but can deliver notable drop-through when the auditoriums are full. If attendance lands at the high end of internal scenarios, leverage on clean operations (and potentially favorable film settlement terms) can expand EBIT above the 13.89 million US dollars consensus. Conversely, if attendance underperforms late in the quarter, leverage can unwind and leave EPS near the low end of expectations.
The third swing factor is pricing and mix between standard and premium formats. Premium large format and upgraded auditoriums tend to lift both ticket pricing and concession attachment, which can stabilize gross margin. A quarter with healthy premium mix can support the gross margin trend even if cost inputs remain firm. Investors should watch any commentary on premium format penetration and April week-by-week box-office updates, as these will influence how the market extrapolates into the summer slate.
Analyst Opinions
Bullish views dominate in the year-to-date period reviewed, resulting in a bullish-to-bearish ratio of 100% to 0%. Several well-followed firms have reiterated or raised constructive stances heading into the report, focusing on early-quarter box-office strength and improving throughput economics.
Wedbush maintained a Buy rating with a 37.00 US dollars price target on April 20, 2026, arguing that momentum from strong early April performance enhances confidence in near-term attendance and the resulting operating leverage. Their stance centers on consensus revenue trending toward 628.89 million US dollars with path-dependent upside should late-quarter titles track above plan; they emphasize the sensitivity of incremental margins to concessions volume in high-traffic periods.
MoffettNathanson raised its target to 34.00 US dollars on April 10, 2026, while reiterating a Buy, underscoring the supportive mix benefits from premium auditoriums and the constructive read-through from the holiday corridor into April. Their view aligns with consensus EBIT of 13.89 million US dollars, framed as a rebound off a light comparable period, with potential to outpace if attendance holds the Easter pace through the month.
Other coverage updates show rising confidence levels as box-office datapoints accumulate. Price target revisions during April clustered in the low-to-mid 30s, consistent with a base case that assumes revenue of 628.89 million US dollars and slightly improving EPS off last year’s trough. The common thread across bullish commentary is that execution on attendance and monetization can generate a measurable lift in earnings versus prior-year levels, even without significant unit growth, given the operating leverage embedded in the model and the resilient concession attachment.
Overall, the majority of analysts expect Cinemark to post a year-over-year revenue increase of 16.99% with adjusted EPS improving to -0.16 and EBIT rebounding, aided by an encouraging start to the quarter and favorable monetization dynamics. The bullish cohort highlights the combination of strong early-quarter attendance signals, the profit contribution from concessions, and the prospects for premium-format mix to support margins. Heading into May 1, 2026, Pre-Market, their base case anticipates Cinemark’s print to validate the recovery trajectory implied by consensus, with the late-April slate performance likely to determine whether results skew toward the high or low end of the range.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.